Exelixis Inc

Healthcare · Biotechnology

56.70$ -2.4% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

Exelixis Inc (EXEL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 2,844 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet EXEL
Line item	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Total Assets	9.0	19	205	347	339	358	291	333	395	412	402	343	361	393	721	503	328	332	598	655	1,422	1,886	2,137	2,616	3,071	2,942	2,948	2,844
Current Assets	–	8.0	120	235	223	244	164	210	262	284	272	230	183	229	433	267	167	179	471	485	897	1,011	1,445	1,835	1,619	1,318	1,468	1,443
Cash	–	5.4	20	36	85	112	78	96	123	135	248	87	97	74	170	104	80	142	152	183	315	267	319	647	501	263	217	482
Cash & Short-Term Investments	–	6.9	113	228	216	237	155	164	179	272	262	203	163	194	411	242	144	167	420	388	693	852	1,207	1,467	1,308	995	1,111	1,059
Receivables	–	0.2	1.5	4.0	3.3	3.8	4.4	7.1	22	6.1	1.5	12	5.9	30	2.8	3.9	4.9	5.2	40	81	179	119	161	283	215	237	265	287
Inventory	–	–	3.6	–	–	–	–	5.4	6.1	0.1	0.0	–	–	0.0	0.0	2.9	2.4	2.6	3.3	6.7	9.8	13	21	27	33	17	22	22
Property, Plant & Equipment	–	–	23	37	32	34	35	36	32	35	36	29	16	8.5	6.1	4.9	2.4	1.4	2.1	26	57	49	67	149	111	–	–	–
Goodwill	–	–	54	62	67	67	67	67	67	64	64	64	64	64	64	64	64	64	64	64	64	64	64	64	64	64	64	64
Intangible Assets	–	–	59	69	72	72	72	3.4	2.6	64	64	64	64	64	64	64	64	64	64	64	–	–	–	–	–	–	–	–
Total Liabilities	–	22	41	109	163	196	241	275	305	327	458	507	589	303	425	437	443	437	508	370	135	200	258	406	583	678	703	683
Current Liabilities	–	8.7	24	40	50	54	64	109	111	133	190	207	200	92	82	88	172	52	271	115	105	143	205	338	324	394	404	406
Short-Term Debt	–	2.3	7.0	7.1	8.7	9.9	11	42	14	16	43	39	38	4.9	13	12	99	418	189	57	57	2.7	3.0	8.7	18	26	25	–
Accounts Payable	–	3.6	10	11	4.7	6.2	5.9	1.7	3.7	9.3	4.9	7.4	2.0	2.0	4.4	9.3	6.4	6.4	6.6	9.6	11	12	24	24	33	34	38	30
Long-Term Debt	–	–	8.0	42	65	101	136	107	108	106	75	40	171	177	323	335	262	381	0.0	0.4	12	–	–	–	–	–	–	–
Shareholders' Equity	-35	-2.8	163	237	176	161	51	34	53	72	-57	-164	-228	91	296	66	-115	-104	89	285	1,287	1,686	1,879	2,211	2,488	2,264	2,244	2,161
Retained Earnings	-36	-55	-130	-201	-287	-382	-519	-604	-705	-792	-955	-1,090	-1,182	-1,106	-1,254	-1,499	-1,767	-1,937	-1,983	-1,829	-880	-559	-448	-217	-34	-173	-99	-77
Shares Outstanding	5.9	5.9	31	46	57	65	73	79	87	99	105	107	109	130	160	184	194	209	251	312	313	315	318	322	325	321	296	282

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings